PLoS ONE (Jan 2017)

Platinum nanoparticles induce damage to DNA and inhibit DNA replication.

  • Lukas Nejdl,
  • Jiri Kudr,
  • Amitava Moulick,
  • Dagmar Hegerova,
  • Branislav Ruttkay-Nedecky,
  • Jaromir Gumulec,
  • Kristyna Cihalova,
  • Kristyna Smerkova,
  • Simona Dostalova,
  • Sona Krizkova,
  • Marie Novotna,
  • Pavel Kopel,
  • Vojtech Adam

DOI
https://doi.org/10.1371/journal.pone.0180798
Journal volume & issue
Vol. 12, no. 7
p. e0180798

Abstract

Read online

Sparsely tested group of platinum nanoparticles (PtNPs) may have a comparable effect as complex platinum compounds. The aim of this study was to observe the effect of PtNPs in in vitro amplification of DNA fragment of phage λ, on the bacterial cultures (Staphylococcus aureus), human foreskin fibroblasts and erythrocytes. In vitro synthesized PtNPs were characterized by dynamic light scattering (PtNPs size range 4.8-11.7 nm), zeta potential measurements (-15 mV at pH 7.4), X-ray fluorescence, UV/vis spectrophotometry and atomic absorption spectrometry. The PtNPs inhibited the DNA replication and affected the secondary structure of DNA at higher concentrations, which was confirmed by polymerase chain reaction, DNA sequencing and DNA denaturation experiments. Further, cisplatin (CisPt), as traditional chemotherapy agent, was used in all parallel experiments. Moreover, the encapsulation of PtNPs in liposomes (LipoPtNPs) caused an approximately 2.4x higher of DNA damage in comparison with CisPt, LipoCisPt and PtNPs. The encapsulation of PtNPs in liposomes also increased their antibacterial, cytostatic and cytotoxic effect, which was determined by the method of growth curves on S. aureus and HFF cells. In addition, both the bare and encapsulated PtNPs caused lower oxidative stress (determined by GSH/GSSG ratio) in the human erythrocytes compared to the bare and encapsulated CisPt. CisPt was used in all parallel experiments as traditional chemotherapy agent.